ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0772

Pediatric Craniofacial Scleroderma: Assessing Handheld 3D Stereophotogrammetric Imaging Feasibility and Reliability

Daniel Glaser1, Kaila Schollaert-Fitch2, Christopher Liu1, Jesse Goldstein1 and Kathryn Torok2, 1UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA

Meeting: ACR Convergence 2021

Keywords: Imaging, Pediatric rheumatology, Scleroderma, Localized

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Pediatric Rheumatology – Clinical Poster II: SLE, JDM, & Juvenile Scleroderma (0764–0785)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Craniofacial scleroderma (Cf-LS), also known as Parry-Romberg Syndrome or scleroderma en coup de sabre, is a subtype of localized scleroderma (morphea). Diagnosis and monitoring of Cf-LS is challenging due to the spectrum of clinical manifestations and lack of robust standardized assessment tools. Digital 3D facial maps help to provide objective assessment of longitudinal facial tissue changes between clinical visits. Traditional stationary camera systems are large, expensive, and require specialized training to use. In contrast, handheld 3D cameras are portable, low-cost, and easy to use. Handheld 3D cameras have been shown to produce reliably high-quality 3D facial maps in adults both with and without craniofacial differences. We set out to determine if the same holds true for children with Cf-LS.

Methods: Digital facial images were obtained on 22 clinically stable Cf-LS patients < 23 years of age (IRB #19080205). Each subject was photographed with a handheld Vectra H2 (Canfield Scientific) and stationary 3dMD.head.t camera systems (3dMD), with a randomized order of acquisition. Number of trials and acquisition time to obtain a satisfactory image were recorded. Descriptive statistics were reported. Consensus facial landmarks (FaceBase Consortium) were digitally applied to each map by two trained individuals. Linear and curvilinear distances between landmarks were measured (VAM software). Reliability statistics and magnitude of error between instruments were calculated.

Results: Subjects ranged in age from 3.5 – 21.5 years with a median disease duration of 6.1 years (Table 1). Mean total image acquisition time was not significantly different between the 3dMD and Vectra camera systems (3dMD = 59 seconds vs. Vectra = 61 seconds, p=0.71). Age was poorly related to acquisition time for both Vectra (Pearson r = -0.07) and 3dMD (Pearson r = -0.32) systems. Height was poorly related to acquisition time for the Vectra system (Pearson r = -0.21) but moderately related for the 3dMD system (Pearson r = -0.41).

Comparing the digital facial maps (Figure 1) from 3dMD and Vectra across 19 inter-landmark linear distances and 2 raters, the median technical error of measurement (TEM) was 1.91mm (range 0.6 – 9.08mm) and the median relative TEM (rTEM) was 3.85% (range 0.80% – 26.42%) (Table 2). Measurements with the highest TEM and rTEM values usually involved oral and/or peri-oral landmarks. Only 36% of subjects had Cf-LS involvement of the lower third of the face. Measurements with the lowest TEM and rTEM values typically included landmarks along the midline of the face.

Conclusion: Handheld 3D cameras are easy to use and generate high quality digital facial maps in children as young as 3 years of age with craniofacial scleroderma, which are overall equivalent to images obtained by stationary cameras. Age and height did not impact the ease of obtaining handheld camera images. Measurements utilizing oral and peri-oral landmarks are most vulnerable to variation due to subtle changes in facial expression between acquisition on both camera systems. Future work will explore the accuracy of longitudinal digital facial maps for disease monitoring in the same population.


Disclosures: D. Glaser, None; K. Schollaert-Fitch, None; C. Liu, None; J. Goldstein, None; K. Torok, None.

To cite this abstract in AMA style:

Glaser D, Schollaert-Fitch K, Liu C, Goldstein J, Torok K. Pediatric Craniofacial Scleroderma: Assessing Handheld 3D Stereophotogrammetric Imaging Feasibility and Reliability [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/pediatric-craniofacial-scleroderma-assessing-handheld-3d-stereophotogrammetric-imaging-feasibility-and-reliability/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pediatric-craniofacial-scleroderma-assessing-handheld-3d-stereophotogrammetric-imaging-feasibility-and-reliability/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology